ROR1 is a pseudokinase that is crucial for MET-driven tumorigenesis

Lignende værker

• An ‘in‐cell trial’ to assess the efficacy of a monovalent anti‐MET antibody as monotherapy and in association with standard cytotoxics
  af: Benvenuti, Silvia, et al.
  Udgivet: (2013)
• Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation
  af: Virzì, Anna Rita, et al.
  Udgivet: (2018)
• MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin
  af: Stella, Giulia M., et al.
  Udgivet: (2017)
• The Met oncogene and basal-like breast cancer: another culprit to watch out for?
  af: Gastaldi, Stefania, et al.
  Udgivet: (2010)
• Negative Feedback Regulation of Met-Dependent Invasive Growth by Notch
  af: Stella, M. Cristina, et al.
  Udgivet: (2005)